Sonova Holding has announced strong results for the first half of its 2026/27 financial year. Group sales reached CHF 1,834.1 million (approx. €1.99bn), up 7.5% in local currencies. Driving these market share gains, says the Swiss multinational, are its Virto R product, the launch of the EON platform, and high volume accounts with huge clients....
Continue reading at Audiology Worldnews
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a financial results announcement with no clinical practice implications.
Sonova's raised guidance signals continued commercial momentum for its Virto R and Eon platform, which may influence product availability, pricing, and competitive dynamics for clinic owners and dispensers.
- 01Sonova reports H1 FY2026/27 group sales of CHF 1,834.1 million, up 7.5% in local currencies.
- 02Full-year financial guidance has been raised following strong H1 performance.
- 03Growth is specifically attributed to the Virto R hearing aid and the Eon platform.
- 04No clinical outcome data or comparative effectiveness evidence is provided.
Sonova achieved H1 group sales of CHF 1,834.1 million, representing 7.5% growth in local currencies.
press releasesupportedGrowth was driven by the Virto R product and the Eon platform.
press releasepartially supported